BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 20812329)

  • 1. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease.
    Haines ML; Ajlouni Y; Irving PM; Sparrow MP; Rose R; Gearry RB; Gibson PR
    Inflamm Bowel Dis; 2011 Jun; 17(6):1301-7. PubMed ID: 20812329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring of thiopurine drugs in patients with inflammatory bowel disease or autoimmune hepatitis.
    Wusk B; Kullak-Ublick GA; Rammert C; von Eckardstein A; Fried M; Rentsch KM
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1407-13. PubMed ID: 15618853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.
    Andoh A; Tsujikawa T; Ban H; Hashimoto T; Bamba S; Ogawa A; Sasaki M; Saito Y; Fujiyama Y
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1373-7. PubMed ID: 18662197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease.
    Kreijne JE; Seinen ML; Wilhelm AJ; Bouma G; Mulder CJ; van Bodegraven AA; de Boer NK
    Ther Drug Monit; 2015 Dec; 37(6):797-804. PubMed ID: 25853923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
    Hoentjen F; Seinen ML; Hanauer SB; de Boer NK; Rubin DT; Bouma G; Harrell LE; van Bodegraven AA
    Inflamm Bowel Dis; 2013 Feb; 19(2):363-9. PubMed ID: 22605661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease.
    Wright S; Sanders DS; Lobo AJ; Lennard L
    Gut; 2004 Aug; 53(8):1123-8. PubMed ID: 15247179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD.
    Spencer E; Norris E; Williams C; Dubinsky MC
    Inflamm Bowel Dis; 2019 Jan; 25(1):142-149. PubMed ID: 29920603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease.
    Cuffari C; Hunt S; Bayless T
    Gut; 2001 May; 48(5):642-6. PubMed ID: 11302961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
    Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
    Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine.
    Armstrong L; Sharif JA; Galloway P; McGrogan P; Bishop J; Russell RK
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1106-14. PubMed ID: 21929546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease.
    Poon SS; Asher R; Jackson R; Kneebone A; Collins P; Probert C; Dibb M; Subramanian S
    J Crohns Colitis; 2015 Aug; 9(8):640-6. PubMed ID: 25968584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience of optimising thiopurine use through metabolite measurement in inflammatory bowel disease.
    Sánchez Rodríguez E; Ríos León R; Mesonero Gismero F; Albillos A; Lopez-Sanroman A
    Gastroenterol Hepatol; 2018 Dec; 41(10):629-635. PubMed ID: 30107940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.
    Gilissen LP; Wong DR; Engels LG; Bierau J; Bakker JA; Paulussen AD; Romberg-Camps MJ; Stronkhorst A; Bus P; Bos LP; Hooymans PM; Stockbrügger RW; Neef C; Masclee AA
    J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?
    Heerasing NM; Ng JF; Dowling D
    Intern Med J; 2016 Apr; 46(4):465-9. PubMed ID: 26425841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases.
    Yarur AJ; Gondal B; Hirsch A; Christensen B; Cohen RD; Rubin DT
    J Clin Gastroenterol; 2018 Jul; 52(6):537-544. PubMed ID: 28723860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laboratory determination of thiopurine levels in paediatric patients with inflammatory bowel disease].
    Martín-Masot R; Ortiz Pérez MP; Ramos Rueda N; Serrano Nieto J; Blasco-Alonso J; Navas-López VM
    An Pediatr (Engl Ed); 2020 Jul; 93(1):34-40. PubMed ID: 31784325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial clinical experience with allopurinol-thiopurine combination therapy in pediatric inflammatory bowel disease.
    Rahhal RM; Bishop WP
    Inflamm Bowel Dis; 2008 Dec; 14(12):1678-82. PubMed ID: 18521913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiopurine therapy in inflammatory bowel disease patients: analyses of two 8-year intercept cohorts.
    Jharap B; Seinen ML; de Boer NK; van Ginkel JR; Linskens RK; Kneppelhout JC; Mulder CJ; van Bodegraven AA
    Inflamm Bowel Dis; 2010 Sep; 16(9):1541-9. PubMed ID: 20155846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study.
    Pavlidis P; Stamoulos P; Abdulrehman A; Kerr P; Bull C; Duley J; Ansari A
    Inflamm Bowel Dis; 2016 Jul; 22(7):1639-46. PubMed ID: 27271488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.